Joseph Murray correspondence with Burroughs Wellcome and Company
Dublin Core
Title
Joseph Murray correspondence with Burroughs Wellcome and Company
Subject
Murray, Joseph E., 1919-2012
Azathioprine
Burroughs Wellcome and Company
Abstract
Letter from Peter Mawdsley of Burroughs Wellcome and Company to Joseph Murray, informing him that the immunosupressive drug Imuran (azathioprine) has received FDA approval for commerical release, to help prevent organ rejection after transplantation.
Creator
Burroughs Wellcome and Company
Date Created
1968 April 10
Rights
The Harvard Medical Library does not hold copyright on all materials in this collection. For use information, consult Public Services at chm@hms.harvard.edu
Access Rights
Access to the original work depicted requires advance notice. Contact Public Services at chm@hms.harvard.edu for additional information
Is Part Of
Joseph E. Murray papers, 1919-2011 (inclusive), H MS c113, Box 47, Folder 24
References
An online guide to the collection is available. Click here.
Format
text
Extent
1 letter
Language
English
Type
text
Identifier
DigID0002587
Files
Citation
Burroughs Wellcome and Company, “Joseph Murray correspondence with Burroughs Wellcome and Company,” OnView, accessed April 28, 2024, https://collections.countway.harvard.edu/onview/items/show/12695.